COURSE DIRECTOR
Jeffrey W. Meeusen, Ph.D. and John R Mills

DESCRIPTION
The Clinical Chemistry Seminar is a recurring meeting covering the latest research and developments in clinical chemistry. The audience is primarily clinical laboratory directors, medical laboratory scientists and students within the Department of Laboratory Medicine and Pathology (DLMP) divisions of Clinical Biochemistry and Immunology (CBI) and Clinical Core Laboratory Services (CCLS). The meeting occurs weekly and discusses topics including clinical test development, biomarker research, new analytical methodologies, and clinical applications of laboratory testing.

TARGET AUDIENCE
Physicians, Resident Fellows, Scientist Researcher PhDs, Students, and Allied Health Professionals

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Integrate new quality and regulatory approaches into their daily clinical laboratory operations.
• Critique new analytical chemistry technologies.
• Assess the utility of new biomarkers for clinical use.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT STATEMENT(S)
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies: 
John R Mills - Intellectual Property -  The Binding Site Group Ltd

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
Jeffrey W. Meeusen, Ph.D.
Dan Dalenberg 
Sara J. Vinje

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

QUESTIONS?
Contact Sara Vinje at ph. 4-3374